Phosphorylation of rhodopsin critically controls the visual transduction cascade by uncoupling it from the G-protein transducin. The kinase primarily responsible for this phosphorylation is rhodopsin kinase, a substrate-regulated kinase that phosphorylates light-activated rhodopsin. Protein kinase C has been implicated in controlling the phosphorylation of both light-activated and darkadapted rhodopsin. Two of the major rhodopsin phosphorylation sites in vivo, Ser 334 and Ser 338 , are effective protein kinase C phosphorylation sites in vitro, while the latter is preferentially phosphorylated by rhodopsin kinase in vitro. Using phosphospecific antibodies against each of these two sites, we show that both sites are under differential spatial and temporal regulation. Exposure of mice to light results in rapid phosphorylation of Ser 338 that is evenly distributed along the rod outer segment. Phosphorylation of Ser 334 is considerably slower, begins at the base of the rod outer segment, and spreads to the top of the photoreceptor over time. In addition, we show that phosphorylation of both sites is abolished in rhodopsin kinase −/− mice, revealing an absolute requirement for rhodopsin kinase to phosphorylate rhodopsin. This requirement may reflect the need for priming phosphorylations at rhodopsin kinase sites allowing for subsequent phosphorylation by protein kinase C at Ser 334 . In this regard, treatment of mouse retinas with phorbol esters results in a 4-fold increase in phosphorylation on Ser 334 , with no significant effect on the phosphorylation of Ser 338 . Our results are consistent with light triggering rapid priming phosphorylations of rhodopsin by rhodopsin kinase, followed by a slower phosphorylation on Ser 334 , which is regulated by protein kinase C.
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INTRODUCTION
The visual receptor, rhodopsin, initiates phototransduction by its light-dependent coupling to the G-protein, transducin [1] [2] [3] . Subsequent deactivation is initiated by phosphorylation of the C-terminus of rhodopsin, an event that promotes arrestin binding and effectively uncouples rhodopsin from transducin. Understanding the molecular mechanisms governing the phosphorylation of rhodopsin is critical to understanding phototransduction. Extensive studies over the past two decades have firmly established that the G-protein-receptor kinase, rhodopsin kinase (RK), is a central player in rhodopsin phosphorylation [4] [5] [6] [7] [8] [9] . This kinase phosphorylates the light-activated conformation of rhodopsin at multiple sites in vitro, with its preferred sites being Ser 338 and Ser 343 [10, 11] . It has also been suggested that a separate kinase, the lipid second-messenger-regulated kinase, protein kinase C (PKC), modulates the phosphorylation of rhodopsin [12] . Treatment of intact retinas with PKC activators (phorbol esters) or inhibitors (calphostin C) alters the light-dependent phosphorylation of rhodopsin [13] [14] [15] . This modulation probably reflects direct phosphorylation of rhodopsin by PKC, as studies with pure proteins have revealed that PKC phosphorylates rhodopsin stoichiometrically [16] . This phosphorylation occurs at two C-terminal sites: an RK site, Ser 338 , and a novel site, Ser 334 [17] . Important progress into understanding the mechanism of rhodopsin phosphorylation resulted from the finding that the three major in vitro sites, Ser 334 , Ser 338 and Ser 343 , are also the sites phosphorylated following exposure of mice to light. Initial MS Abbreviations used: Ac, acetyl; DMEM, Dulbecco's modified Eagle's medium; EM, electron microscopy; KLH, keyhole limpet haemocyanin; PKC, protein kinase C; pS, phosphoserine; RK, rhodopsin kinase; ROS, rod outer segment. 1 To whom correspondence should be addressed (e-mail anewton@ucsd.edu).
studies identified Ser 338 and Ser 334 as the primary sites that are phosphorylated in live mice exposed to constant light [18] . More recent studies, using novel rapid-quench/MS-based analyses, revealed that a third site, Ser 343 , also becomes significantly phosphorylated [19] . Functional analyses of rods from transgenic mice expressing rhodopsin mutated in one or more phosphorylation sites reveals that phosphorylation of each site is involved in rhodopsin deactivation, and, specifically, mutation of any of these sites to alanine slows the deactivation kinetics of rhodopsin [20] . The requirement for multiple phosphorylation events to regulate rhodopsin begs the question as to what mechanisms regulate these phosphorylations: are the events ordered, are they catalysed by different kinases, and what is their spatial and temporal resolution?
In the present study, we generated phosphospecific antibodies to address the regulation of rhodopsin phosphorylation at Ser 334 and Ser 338 . Our results suggest an ordered phosphorylation of rhodopsin that depends on RK for the first step and PKC for the second step.
EXPERIMENTAL

Materials
Frozen bovine retinas were kindly provided by Dr Yee-Kin Ho (Department of Biochemistry and Molecular Biology, University of Illinois, College of Medicine, Chicago, IL, U.S.A.). Balb/c mice were purchased from Taconic (Germantown, NY, U.S.A.). Nitrocellulose was purchased from Bio-Rad, calf intestinal phosphatase was from New England Biolabs, and PVDF was from Millipore. DMEM (Dulbecco's modified Eagle's medium) was obtained from BioWhittaker. PMA and BSA were purchased from Calbiochem. DMSO was purchased from Sigma. All other chemicals were reagent-grade.
Generation of phosphospecific antibodies
Synthesis of phosphorylated peptides, immunization of rabbits, and collection of sera were performed by Multiple Peptide Systems (San Diego, CA, U.S.A.). The sequence for the peptide containing phosphorylated Ser 334 was Ac-CLGDDEA-pS-ATAS-NH 2 (where Ac is acetyl), that for the peptide containing phosphorylated Ser 338 was Ac-CASATA-pS-KTETSQ-NH 2 , and that for the peptide phosphorylated at both Ser 334 and Ser 338 was Ac-CLGDDEA-pS-ATA-pS-KTETSQA-NH 2 , where pS denotes phosphoserine. Mono-and di-phosphorylated peptides were conjugated through the N-terminal cysteine thiol to keyhole limpet haemocyanin (KLH). Monophosphorylated antigens were subcutaneously injected into six New Zealand white rabbits, aged 3-9 months. Antisera from all six rabbits produced phosphospecific antibodies of comparable titre; antibodies from the fourth bleed were affinity purified by applying crude antisera to a gel cross-linked with the appropriate synthetic phosphopeptide. Antibodies were eluted at low pH into a neutralizing buffer. Antibodies are referred to as α-P334 and α-P338; similar results were obtained using crude or affinity-purified antibodies. 
Rhodopsin purification
Rod outer segments (ROSs) were isolated from 50 bovine retinas as described by Papermaster and Dreyer [21] ; isolation was performed in the light so that rhodopsin was phosphorylated. Membranes were urea-stripped as described in [16] . ROS membranes were incubated with calf intestinal phosphatase for 20 min at 30
• C to dephosphorylate rhodopsin. Samples were subjected to SDS/PAGE, transferred on to PVDF, and blotted with antisera at 1 : 1000 dilution. Total opsin was detected with the monoclonal 1D4 antibody, kindly provided by Dr Robert Molday (Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada).
In vitro rhodopsin phosphorylation
Dark-adapted, urea-stripped ROS membranes were treated with alkaline phosphatase (0.01 unit) for 30 min at 30
• C to ensure that there was no residual phosphate on rhodopsin and then were washed in 20 mM Hepes buffer to remove phosphatase. ROS membranes were subsequently phosphorylated by incubation with PKC-α (125 nM), 5 mM MgCl 2 and 100 µM ATP, as described, for 60 min [17] . Reactions were quenched with SDS/PAGE sample buffer and samples were analysed in duplicate on 10 % (w/v) polyacrylamide gels. One set of gels was stained with Coomassie Blue to detect protein, rhodopsin bands were excised, and 32 P incorporation into rhodopsin was quantified by liquid scintillation counting. Samples from the second set of gels were transferred on to PVDF for Western blot analysis. Blots were probed with 1 : 1000 dilutions of monoclonal 1D4 and polyclonal α-P334 and α-P338 antibodies.
In vivo time course of rhodopsin phosphorylation
Albino (Balb/c) mice were raised with a light/dark cycle of 12 h : 12 h until the age of 10 weeks. Mice were dark-adapted overnight before light exposure. The experiment was initiated by illuminating the mice with 100 lux white light (small light box). At appropriate time points, mice were killed and both retinas were harvested by dissection. Retinas were immediately flash frozen, then resuspended and homogenized in SDS/PAGE sample buffer. Two retinas were analysed for each time point. Three separate gels were run: two for Western blot analyses (0.2 retina per lane), with each of the two phosphospecific antibodies, and one for Western blot analysis (0.02 retinas per lane), with an antibody that does not discriminate between phosphorylation states of rhodopsin, 1D4. Antibody staining was detected by chemiluminescence and was quantified by CCD (charge-coupled device) camera using a GeneGnome bioimaging system (Syngene, Frederick, MD, U.S.A.).
Rhodopsin-kinase-knockout mice
Mice, aged approx. 6 months, were generated in a pigmented (C57/B6) background by Dr Jason Chen (Departments of Ophthalmology and Human Genetics, University of Utah, Salt Lake City, UT, U.S.A.) as described in [22] and were exposed to 1000 lux white light. Pigmented rhodopsin-kinase-knockout mice, wild-type pigmented litter-mates and albino controls were illuminated together for specified times. Total opsin was detected using α-opsin polyclonal antibodies.
In situ retina experiments
Retinas from albino mice were dissected under dim red light, at which point retinas from each mouse were separated into two tubes containing 1 ml of DMEM. Retinas were allowed to equilibrate for 15 min before the addition of 1 µM PMA to one retina and DMSO to the other retina from the same mouse. The retinas were incubated with PMA or DMSO for 15 min before illumination with 325 lux white light. After 15 min of constant light, the retinas were removed from the solution and were flash frozen. Retinas were solubilized in 1 ml of SDS/PAGE sample buffer and one-tenth of the sample was analysed with each phosphospecific antibody, and one-hundredth was analysed using the total opsin antibody, 1D4.
Immunoelectron microscopy
After exposure to light (see the 'In vivo time course of rhodopsin phosphorylation' section above), eyes were quickly removed from the mice and immersed in 1 % (w/v) glutaraldehyde and 2 % (w/v) paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The eyes were then processed as described in [23] . Anterior segments were immediately dissected away while in fixative to yield eyecups. After 2 h at room temperature (25 • C), the eyecups were then dissected into small pieces. The retinal pieces were dehydrated through an ethanol series up to 90 %, infiltrated in a 1 : 1 mixture of LR White resin (Electron Microscopy Sciences, Fort Washington, PA, U.S.A.) and 90 % ethanol for 1 h, and then infiltrated overnight in pure LR White at 4
• C. They were embedded in the fresh resin and polymerized at 60
• C for 24 h. Ultrathin sections (60-70 nm) were collected on Formvar-coated nickel grids. Sections were first etched with saturated sodium periodate (Sigma), then blocked with 4 % (w/v) BSA in PBS for 30 min. The primary incubation was carried out overnight at 4
• C with affinity-purified α-P334 and α-P338 antibodies (1 : 800 dilution) in PBS containing 1 % (w/v) BSA. The sections were rinsed with PBS, and were then incubated with goat anti-rabbit IgG conjugated to 10 nm diameter gold particles (Amersham Biosciences) at a dilution of 1 : 30 in PBS with 1 % (w/v) BSA for 1 h. Sections were post-fixed in 2 % (w/v) glutaraldehyde for 20 min, washed in distilled water and stained with 5 % (w/v) uranyl acetate for 5 min before observation. They were then observed in a JEOL (Model 1200-EX) transmission electron microscope. Electron microscopy (EM) negatives were scanned in an Agfa Duoscan T2500 scanner.
RESULTS AND DISCUSSION
Generation and characterization of phosphospecific antibodies
To examine the spatial and temporal phosphorylation of two major in vivo rhodopsin phosphorylation sites in live animals, we generated phosphospecific antibodies against Ser 334 and Ser 338 on the C-terminal tail of rhodopsin ( Figure 1A ). Two phosphopeptides, P334 and P338, were chemically synthesized and used to generate α-P334 and α-P338 antibodies (see the Experimental section). Both antibodies were tested for phosphospecificity by probing KLH-coupled phosphopeptides or KLH alone immobilized on nitrocellulose with affinity-purified antibodies. Figure 1 (B) shows that each antibody was specific for the phosphorylated residue it was generated against: α-P334 exclusively labelled the P334 peptide, and α-P338 exclusively labelled the P338 peptide. Importantly, phosphorylation at a 5) were probed with 1D4, α-P334 and α-P338 antibodies to generate a standard curve. Both phosphospecific antibody blots were exposed for the same length of time. Lane 6 represents a retinal sample from mice exposed to illumination and corresponds to the 30 min in vivo sample seen in Figure 3 . The single asterisk refers to the rhodopsin monomer and the double asterisk refers to the rhodopsin dimer.
second position did not affect the affinity of the antibody for the first site: Figure 1(B) shows that the α-P334 antibody bound the peptide phosphorylated at Ser 334 and the peptide phosphorylated at both Ser 334 and Ser 338 equally well. Similarly, the α-P338 antibody recognized the peptide phosphorylated at Ser 338 and the peptide phosphorylated at both Ser 338 and Ser 334 with comparable affinity. The phosphospecific antibodies were further characterized on Western blots using full-length rhodopsin: each antibody effectively labelled phosphorylated bovine rhodopsin ( Figure 1C, lane 2) , but not unphosphorylated rhodopsin ( Figure 1C, lane 1) . Thus each antibody was specific for phosphorylated rhodopsin at the relevant phosphorylation site and labelled the site against which it was directed, independently of phosphorylation at other sites.
We next addressed the sensitivity of the phosphospecific antibodies towards various concentrations of rhodopsin phosphorylated to a known stoichiometry (Figure 2) . Rhodopsin was phosphorylated in vitro with pure PKC-α to a stoichiometry of 0.4 mol of phosphate per mol of rhodopsin. We have shown previously that, under the conditions of these phosphorylation assays, Ser 334 and Ser 338 each incorporate approx. 35 % of the total phosphate [17] . Thus, in the experiment in Figure 2 , each site was phosphorylated to a stoichiometry of 0.15 mol of phosphate per mol of rhodopsin. Triplicate blots were analysed with either antibody 1D4 to probe for total opsin or the phosphospecific antibodies α-P334 and α-P338. Opsin migrated primarily as a monomer (Figure 2 , single asterisk), with some dimer apparent at the highest concentrations (Figure 2, double asterisks) . Antibody 1D4 detected the lowest concentration of rhodopsin tested: 0.03 pmol (Figure 2, lane 1) . Both α-P334 and α-P338 detected the second lowest concentration of phosphorylated opsin: 0.1 pmol (Figure 2, lane 2) . This corresponds to a detection limit for each phosphospecific antibody of 0.02 pmol of phosphate per site. Thus both phosphospecific antibodies have similar affinities for phosphorylated sequences and are highly sensitive, with detection down to 0.02 pmol of phosphate. This analysis also included a sample of retina from a live mouse exposed to illumination (Figure 2, lane 6) . Quantification of the intensities of the signals in the blots revealed that 0.09 pmol of opsin had been analysed and that it was phosphorylated to a stoichiometry of 0. We first took advantage of the phosphospecific antibodies to explore the time-dependence of phosphorylation at Ser 334 and Ser 338 in mice exposed to constant illumination. Albino mice were dark-adapted overnight to ensure quantitative dephosphorylation of rhodopsin and were then exposed to constant illumination (approx. 100 lux). Mice were killed immediately before illumination or after 1, 10, 30 or 60 min illumination. Lane 1 of Figure 3 (A) shows that rhodopsin from dark-adapted animals was not labelled by either phosphospecific antibody, but was labelled by a monoclonal antibody to rhodopsin that does not discriminate between phosphorylation states, 1D4. Following 1 min of illumination, weak, but readily detectable, labelling by α-P338 antibody was observed, whereas barely detectable labelling was observed using α-P334 antibody ( Figure 3A , lane 2). The labelling by α-P338 antibody peaked at 10 min ( Figure 3A , lane 3), when the signal had increased dramatically to > 1000-fold that of the background. The signal then decreased with similar kinetics to its appearance, with approx. 10 % of the maximal signal observed following 60 min of illumination. In contrast with the rapid and transient labelling by α-P338 antibody, the labelling by α-P334 antibody continued to increase slowly through 60 min of illumination ( Figure 3A , lane 5). The stoichiometry of phosphorylation at each site was determined using the standard curve in Figure 2 . The kinetics of phosphorylation at each site are plotted in Figure 3( The generation of phosphospecific antibodies allowed us the unique opportunity to explore the spatial distribution of rhodopsin phosphorylated at each site using EM. Retinas from mice exposed to the same illumination conditions as those for the experiment shown in Figure 3 were isolated and fixed for use in EM. Figure 4 shows that, following 5 min illumination, Ser 338 staining occurred over the entire length of the ROS. In contrast, staining by α-P334 antibody was concentrated in the proximal end of the ROS. Following 60 min of illumination, the entire ROS was evenly phosphorylated at Ser 334 and Ser 338 , as judged by uniform labelling with these two phosphospecific antibodies (results not shown). In addition, the overall level of labelling by α-P338 antibody was considerably reduced at 60 min compared with 5 min, consistent with the biochemical analysis from Figure 3 that showed that most of the rhodopsin was dephosphorylated at Ser 338 following 60 min of illumination. Retinas from darkadapted mice were not significantly labelled by either antibody (results not shown). These results indicate a spatial distribution of rhodopsin phosphorylation at Ser 334 and Ser 338 that has not previously been reported.
One possible explanation for a gradient of phosphorylation could be the direction of light input. Incoming light presumably strikes the proximal region of ROSs initially, and, over time, proceeds distally. However, the observed gradient of phosphorylation at Ser 334 is present following 5 min of constant illumination, well after light has activated rhodopsin at the distal tip of the ROS, as demonstrated by P338 staining. As a result, it is unlikely that the gradient of Ser 334 phosphorylation results directly from the direction of light input. An alternative possibility is that phosphorylation of Ser 338 (or possibly Ser 343 [19] ) is required to 'prime' rhodopsin for subsequent phosphorylation at Ser 334 . This priming step would probably also involve the dephosphorylation of Ser 338 , because phosphorylation of Ser 334 becomes significant only after Ser 338 phosphorylation has peaked (see Figure 3B ). 
RK is required for phosphorylation of Ser 334 and Ser
338
The delayed temporal and spatial distribution of Ser 334 phosphorylation compared with Ser 338 phosphorylation led us to explore the role of a second kinase in regulating rhodopsin phosphorylation in vivo. First, we asked whether or not phosphorylation by RK was necessary for phosphorylation at Ser 334 , the candidate site for a second kinase, using RK knock-out mice. RK −/− pigmented mice, as well as their wild-type control littermates, were exposed to light for increasing amounts of time. Since these animals were bred into a pigmented background, we increased the light intensity 10-fold to compensate for less efficient absorption of light by rhodopsin. Albino mice were included to assess whether these lighting conditions simulated the previous time course.
The upper panel in Figure 5 (A) shows the total opsin in retinal samples from pigmented RK knockout mice ( Figure 5A, lanes  1-3) , pigmented wild-type litter-mates ( Figure 5A, lanes 4-6) , and albino wild-type mice ( Figure 5A, lanes 7-9) . Slightly less opsin was detected in the RK −/− mice as they were raised with a light/dark cycle of 12 h : 12 h. This lowered amount of opsin probably arises because the ROSs from RK −/− animals undergo light-induced apoptosis and are thus shorter than the ROSs of wild-type mice [22] . Comparison of data from wild-type pigmented ( Figure 5A , lanes 4-6) and albino ( Figure 5A, lanes 7-9) mice revealed similar kinetics of phosphorylation of Ser 334 and similar stoichiometry (i.e. the ratio of labelling by α-P334 antibody to total opsin was the same in the albino and pigmented mice). The kinetics of labelling by α-P338 antibody were also similar for the two wild-type mice strains, but differed from the labelling observed for albino mice at lower light levels in that the phosphorylation was sustained. This sustained phosphorylation at both sites could arise from the increased light intensity, which presumably pushes the phosphorylated/dephosphorylated equilibrium towards the phosphorylated state. Curiously, the labelling by α-P338 antibody was markedly reduced (approx. 3-fold) in the pigmented mice relative to the albino mice. Assuming that the only difference between these wild-type mice strains is a lack of pigment in the albino mice, then this difference can be accounted for by the increased light sensitivity of the albino mice. The finding that pigmentation affects phosphorylation of Ser 338 , but not Ser 334 , underscores the possibility that the phosphorylation of each site is under the control of two mechanisms, and suggests further that phosphorylation of Ser 338 has greater light-dependence than that of Ser 334 . Phosphorylation of both Ser 334 and Ser 338 was not observed in RK −/− mice ( Figure 5A, lanes 1-3) , even following 4 h exposure to constant illumination. The faint signal at the appropriate molecular mass for rhodopsin in the RK −/− mice results from non-specific labelling of a non-rhodopsin protein, since this band remains following boiling of these samples to quantitatively abolish monomeric rhodopsin on SDS/PAGE (results not shown). This lack of phosphorylation at both sites is consistent with MS studies of RK −/− mice showing > 10-fold reduction in total lightdependent rhodopsin phosphorylation [22] .
Phosphorylation of Ser 334 is increased following the activation of PKC
The RK −/− studies suggest that RK is required for rhodopsin phosphorylation at both Ser 334 and Ser 338 . Electrophysiological studies also support the requirement of RK for normal deactivation kinetics [25] . This necessity for RK could arise because of an ordered phosphorylation mechanism in which Ser 338 must be phosphorylated first to allow a second kinase to phosphorylate the more slowly phosphorylated site, Ser 334 . Since PKC activity modulates the phosphorylation state of rhodopsin in vivo, we explored the effects of PMA on the light-dependent phosphorylation of Ser 334 and Ser 338 . Retinas from albino mice were dissected and incubated with or without 1 µM PMA and were then exposed to constant illumination for 15 min. As previously shown, this is a condition which causes an increase in the light-dependent phosphorylation of rhodopsin using 32 P as a phosphorylation indicator [25] . Figure 5 (B) demonstrates that PMA treatment caused a 4-fold increase in the phosphorylation of Ser 334 relative to control retinas treated with DMSO. In contrast, PMA treatment had no significant increase on the phosphorylation of Ser 338 . We have previously shown that phorbol ester treatment of retinas does not affect RK activity [14] . The time course in Figure 3( Thus it is more likely that, following dephosphorylation of Ser 338 , the conformation or macromolecular interactions of rhodopsin are altered in a manner to allow PKC recognition. Such alterations could arise from isomerization of neighbouring proline residues by prolyl isomerases that may be phosphorylation-specific [26] . Alternatively, the second-messenger pathway activating PKC could depend on the activity of RK.
CONCLUSIONS
Previous studies have clearly established the requirement of phosphorylation at Ser 334 and Ser 338 in controlling the physiological function of rhodopsin [22, 25] . In the present study, we take advantage of phosphospecific antibodies to show that the phosphorylation of these sites is under the co-ordinated regulation of two mechanisms. There is an initial priming phosphorylation catalysed by RK at Ser 338 and, based on the study of Hurley and coworkers [19] , probably Ser 343 . This species of rhodopsin is rapidly dephosphorylated, an event which allows for the phosphorylation of Ser 334 . The second, but not first, phosphorylation mechanism is controlled by PKC as phorbol esters promote the phosphorylation of Ser 334 , but not Ser 338 . Our finding that PKC activation selectively affects the phosphorylation of Ser 334 is consistent with this residue being a major in vitro site for PKC [17] . The use of phosphospecific antibodies, coupled with genetic and pharmacological manipulation of kinases, has allowed, for the first time, insight into the temporal and spatial regulation of rhodopsin phosphorylation. This significantly underscores the key role of a priming kinase, RK, and a secondary kinase, PKC, in rhodopsin function.
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